{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:35:26Z","timestamp":1792035326563,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM086596"],"award-info":[{"award-number":["R01GM086596"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jsbmb.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T23:18:00Z","timestamp":1454800680000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"special_numbering":"PA","title":["Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic"],"prefix":"10.1016","volume":"165","author":[{"given":"Richard J.","family":"Auchus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2016.02.002_bib0005","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1074\/jbc.M114.627265","article-title":"Structural and kinetic basis of steroid 17\u03b1,20-lyase activity in teleost fish cytochrome P450 17A1 and its absence in cytochrome P450 17A2","volume":"290","author":"Pallan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0010","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1210\/en.2007-0487","article-title":"A novel type of P450c17 lacking the lyase activity is responsible for C21-steroid biosynthesis in the fish ovary and head kidney","volume":"148","author":"Zhou","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jcem-63-3-789","article-title":"Assignment of the gene for adrenal P450c17 (17\u03b1-hydroxylase\/17,20 lyase) to human chromosome 10","volume":"63","author":"Matteson","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/dna.1987.6.439","article-title":"Cloning and sequence of the human gene encoding P450c17 (steroid 17\u03b1-hydroxylase\/17,20 lyase): similarity to the gene for P450c21","volume":"6","author":"Picado-Leonard","year":"1987","journal-title":"DNA"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.84.2.407","article-title":"Cytochrome P450c17 (steroid 17\u03b1-hydroxylase\/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues","volume":"84","author":"Chung","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0030","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.3535074","article-title":"Expression of bovine 17\u03b1-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS-1) cells","volume":"234","author":"Zuber","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2265.2000.01144.x","article-title":"Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies","volume":"53","author":"Suzuki","year":"2000","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2003-031020","article-title":"Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells","volume":"89","author":"Costa-Santos","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0045","doi-asserted-by":"crossref","first-page":"e25492","DOI":"10.1371\/journal.pone.0025492","article-title":"CYP17A1 intron mutation causing cryptic splicing in 17\u03b1-hydroxylase deficiency","volume":"6","author":"Hwang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0050","first-page":"133","article-title":"17-Hydroxylase\/17,20 lyase deficiency diagnosed during childhood","volume":"57","author":"Wolthers","year":"2002","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tem.2004.07.005","article-title":"P450-oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations","volume":"15","author":"Miller","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2003-031021","article-title":"Two prevalent CYP17 mutations and genotype\u2013phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency","volume":"89","author":"Costa-Santos","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsbmb.2015.02.007","article-title":"New, recurrent, and prevalent mutations: clinical and molecular characterization of 26 Chinese patients with 17\u03b1-hydroxylase\/17,20-lyase deficiency","volume":"150","author":"Zhang","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0075","first-page":"489","article-title":"Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17\u03b1-hydroxylase deficiency","volume":"77","author":"Fardella","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00207050","article-title":"Canadian Mennonites and individuals residing in the Friesland region of the Netherlands share the same molecular basis of 17\u03b1-hydroxylase deficiency","volume":"89","author":"Imai","year":"1992","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0085","first-page":"3797","article-title":"Mutation of cytochrome P-45017\u03b1 gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17","volume":"81","author":"Miura","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1097-201","article-title":"The genetic and functional basis of isolated 17,20 lyase deficiency","volume":"17","author":"Geller","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/mend.13.1.0219","article-title":"P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5","volume":"13","author":"Geller","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/bi051623y","article-title":"Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17","volume":"45","author":"Naffin-Olivos","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0105","doi-asserted-by":"crossref","first-page":"33838","DOI":"10.1074\/jbc.M114.608919","article-title":"Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5","volume":"289","author":"Peng","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0110","doi-asserted-by":"crossref","first-page":"48563","DOI":"10.1074\/jbc.M307586200","article-title":"CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding","volume":"278","author":"Sherbet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1530\/EJE-07-0712","article-title":"Metabolic evidence for impaired 17\u03b1-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity","volume":"158","author":"Tiosano","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0120","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2008-0051","article-title":"Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency","volume":"93","author":"Hershkovitz","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2011-2161","article-title":"The syndrome of 17,20 lyase deficiency","volume":"97","author":"Miller","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2014.11.026","article-title":"The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)","volume":"151","author":"Yoshimoto","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0135","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1021\/bi00517a014","article-title":"Microsomal cytochrome P450 from neonatal pig testis: two enzymatic activities (17\u03b1-hydroxylase and C17,20-lyase) associated with one protein","volume":"20","author":"Nakajin","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0006-291X(82)90850-6","article-title":"Cytochrome b5 stimulates purified testicular microsomal cytochrome P450 (C21 side-chain cleavage)","volume":"108","author":"Onoda","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/abbi.1995.1173","article-title":"The role of cytochrome b5 in the biosynthesis of androgens by human P450c17","volume":"317","author":"Katagiri","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/bj3320293","article-title":"Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b5","volume":"332","author":"Lee-Robichaud","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0155","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.abb.2003.07.003","article-title":"5\u03b1-reduced C21 steroids are substrates for human cytochrome P450c17","volume":"418","author":"Gupta","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0165","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/jc.2008-1745","article-title":"Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X","volume":"95","author":"Kok","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0170","doi-asserted-by":"crossref","first-page":"E465","DOI":"10.1210\/jc.2011-2413","article-title":"A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency","volume":"97","author":"Idkowiak","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0175","first-page":"98","article-title":"Progesterone 16\u03b1-hydroxylase activity is catalyzed by human cytochrome P450 17\u03b1-hydroxylase","volume":"77","author":"Swart","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsbmb.2009.12.014","article-title":"A single amino acid residue Ala 105, confers 16\u03b1-hydroxylase activity to human cytochrome P450 17\u03b1-hydroxylase\/17,20 lyase","volume":"119","author":"Swart","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0185","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1021\/bi300895w","article-title":"Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates","volume":"51","author":"Yoshimoto","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0195","doi-asserted-by":"crossref","first-page":"32952","DOI":"10.1074\/jbc.M114.610998","article-title":"Structures of human steroidogenic cytochrome P450 17A1 with substrates","volume":"289","author":"Petrunak","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0200","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/bi102078e","article-title":"Why human cytochrome P450c21 is a progesterone 21-hydroxylase","volume":"50","author":"Mizrachi","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0205","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2265.2003.01858.x","article-title":"Adrenarche\u2014physiology, biochemistry and human disease","volume":"60","author":"Auchus","year":"2004","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0889-8529(18)30267-6","article-title":"17\u03b1-hydroxylation deficiency","volume":"20","author":"Biglieri","year":"1991","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0220","doi-asserted-by":"crossref","first-page":"K19","DOI":"10.1530\/EJE-14-0834","article-title":"Partial deficiency of 17\u03b1-hydroxylase\/17,20-lyase caused by a novel missense mutation in the canonical cytochrome heme-interacting motif","volume":"172","author":"Rubtsov","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0225","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1177\/1470320315585683","article-title":"The relationship between the polymorphisms of the CYP17A1 gene and hypertension: a meta-analysis","volume":"16","author":"Dai","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0230","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng.361","article-title":"Genome-wide association study identifies eight loci associated with blood pressure","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000179481","article-title":"Dexamethasone-suppressible hypercorticosteronism in two 46,XX subjects with ambiguous genitalia and ovarian cysts. Partial defect of 17\u03b1-hydroxylase or 17-20-desmolase","volume":"16","author":"Roger","year":"1982","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/humrep\/deh065","article-title":"Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46,XY sister: case report","volume":"19","author":"ten Kate-Booij","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.41.213","article-title":"A case of 17a-hydroxylase deficiency with retained menstruation","volume":"41","author":"Katayama","year":"1994","journal-title":"Endocr. J."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0250","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0015-0282(00)00500-8","article-title":"Induction of endometrial cycles and ovulation in a woman with combined 17\u03b1-hydroxylase\/17,20-lyase deficiency due to compound heterozygous mutations on the p45017alpha gene","volume":"73","author":"Matsuzaki","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0255","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/jcem-68-3-693","article-title":"In vitro fertilization and primary embryonic cleavage are possible in 17\u03b1-hydroxylase deficiency despite extremely low intrafollicular 17\u03b2-estradiol","volume":"68","author":"Rabinovici","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0260","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1210\/jc.2001-011880","article-title":"Differential inhibition of 17\u03b1-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency","volume":"87","author":"Van Den Akker","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0265","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.fertnstert.2004.11.063","article-title":"Isolated 17,20-lyase (desmolase) deficiency in a 46,XX female presenting with delayed puberty","volume":"83","author":"Simsek","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0270","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0889-8529(18)30101-4","article-title":"Disorders of steroid 17\u03b1-hydroxylase deficiency","volume":"23","author":"Kater","year":"1994","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0275","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/jc.2003-030988","article-title":"P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping","volume":"88","author":"Martin","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0280","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0285","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome","volume":"36","author":"Fl\u00fcck","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0290","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1210\/jc.2011-0640","article-title":"Genotype\u2013phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"97","author":"Krone","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(83)91166-X","article-title":"Distinctive plasma aldosterone, 18-hydroxycorticosterone, and 18-hydroxydeoxycorticosterone profile in the 21- 17\u03b1-, and 11\u03b2-hydroxylase deficiency types of congenital adrenal hyperplasia","volume":"75","author":"Kater","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0300","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9440(10)63112-4","article-title":"Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance","volume":"164","author":"Holzbeierlein","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0310","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1038\/sj.onc.1204889","article-title":"Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling","volume":"20","author":"Mousses","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0315","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2310\/JIM.0b013e3182408567","article-title":"Human steroid biosynthesis for the oncologist","volume":"60","author":"Auchus","year":"2012","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0320","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm00013a022","article-title":"Novel steroidal inhibitors of human cytochrome P45017\u03b1 (17\u03b1-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer","volume":"38","author":"Potter","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0325","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1200\/JCO.2007.15.9749","article-title":"Phase I clinical trial of a selective inhibitor of CYP17 abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven","volume":"26","author":"Attard","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.01.013","article-title":"A-Ring modified steroidal azoles retain similar potent and slowly reversible CYP17A1 inhibition as abiraterone","volume":"143","author":"Garrido","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0335","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jc.2011-2189","article-title":"Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer","volume":"97","author":"Attard","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0340","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","article-title":"Long-term follow-up of bone mineral density in Addison\u2019s disease","volume":"58","author":"Jodar","year":"2003","journal-title":"Clin. Endocrinol. (Oxford)"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0345","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0350","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0039-128X(94)00018-8","article-title":"Long-term treatment of mineralocorticoid excess syndromes","volume":"60","author":"Mantero","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2016.02.002_bib0360","first-page":"48","article-title":"17\u03b1-Hydroxylase deficiency: 1963\u20131966","volume":"82","author":"Biglieri","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016300164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:52:45Z","timestamp":1760745165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016300164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":72,"alternative-id":["S0960076016300164"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.02.002","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}